Prajapat, R., & Jain, S. (2023). Analysis the Effectiveness of Remdesivir, Galidesivir, Sofosbuvir, Tenofovir and Ribavirin as Potential Therapeutic Drug target against SARS-Cov-2 RNA-Dependent RNA Polymerase (RdRp): An in Silico Docking Study. Urmia University of Medical Sciences.
Chicago Style (17th ed.) CitationPrajapat, Rajneesh, and Suman Jain. Analysis the Effectiveness of Remdesivir, Galidesivir, Sofosbuvir, Tenofovir and Ribavirin as Potential Therapeutic Drug Target Against SARS-Cov-2 RNA-Dependent RNA Polymerase (RdRp): An in Silico Docking Study. Urmia University of Medical Sciences, 2023.
MLA引文Prajapat, Rajneesh, and Suman Jain. Analysis the Effectiveness of Remdesivir, Galidesivir, Sofosbuvir, Tenofovir and Ribavirin as Potential Therapeutic Drug Target Against SARS-Cov-2 RNA-Dependent RNA Polymerase (RdRp): An in Silico Docking Study. Urmia University of Medical Sciences, 2023.